Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women

Abstract

BACKGROUND: The Glu27Glu genotype in the beta-2-adrenergic receptor (ADRB2) is associated with fat mass, body mass index and obesity in females. In our population, we previously found an association of higher body mass index (BMI) among women who reported more physical activity and carried the Glu27 allele as compared to non carriers with the same level of activity.

OBJECTIVE: To examine the lipid metabolism differences, both at rest and during submaximal exercise in ADRB2 Glu27Glu vs Gln27Gln obese women.

SUBJECTS: Eight obese women with the Glu27Glu genotype (age, 43±5 y; body mass index (BMI), 31.7±0.9 kg/m2; percentage fat mass, 42.0±1.3; WHR, 0.83±0.02; and VO2max, 21.6±0.9 ml/kg/min) were compared with seven obese women with the Gln27Gln genotype (age, 43±5 y; BMI, 33.9±1.3 kg/m2; percentage fat mass, 41.6±1.2; WHR, 0.83±0.02; and VO2max, 20.6±0.8 ml/kg/min).

MEASUREMENTS: The ADRB2 polymorphism was identified by PCR-RFLP. Respiratory quotient was determined by indirect calorimetry at baseline, during 1 h of walking on a treadmill and 1 h after the exercise. Plasma triglycerides, glycerol, FFA, hydroxybutyrate, glucose and lactate were assayed by spectrophotometric methods. Insulin, leptin and progesterone were measured by radioimmunoassay. Adrenaline and noradrenaline were quantified by high performance liquid chromatography.

RESULTS: The ADRB2 Glu27Glu subjects had lower plasma glycerol (P=0.047) and lower hydroxybutyrate (P=0.001) throughout the study than the Gln27Gln group. Plasma triglycerides (P=0.001), lactate (P<0.05) and serum insulin (P<0.05) remained higher in the Glu27Glu group vs the Gln27Gln group. The respiratory quotient (RQ) was higher in the Glu27Glu obese women along the study (P=0.046), and fat oxidation was significantly lower in this group during the recovery (P=0.048). The other variables did not differ statistically between groups.

CONCLUSION: These data suggest that both lipolysis and fat oxidation promoted by an acute submaximal exercise intervention could be blunted in the polymorphic ADRB2 Glu27Glu group of our female obese population.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Sakane N, Yoshida T, Umekawa T, Kogure A, Kondo M . Beta2-adrenoceptor gene polymorphism and obesity Lancet 1999 353: 1976.

    Article  CAS  PubMed  Google Scholar 

  2. Reynisdottir S, Wahrenberg H, Carlstrom K, Rossner S, Arner P . Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors Diabetologia 1994 37: 428–435.

    Article  CAS  PubMed  Google Scholar 

  3. Enoksson S, Talbot M, Rife F, Tamborlane WV, Sherwin RS, Caprio S . Impaired in vivo stimulation of lipolysis in adipose tissue by selective beta2-adrenergic agonist in obese adolescent girls Diabetes 2000 49: 2149–2153.

    Article  CAS  PubMed  Google Scholar 

  4. Schiffelers SL, Saris WH, Boomsma F, van Baak MA . beta(1)- and beta(2)-Adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men J Clin Endocrinol Metab 2001 86: 2191–2199.

    CAS  PubMed  Google Scholar 

  5. Hall IP . Beta 2 adrenoceptor polymorphisms: are they clinically important? Thorax 1996 51: 351–353.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Green SA, Turki J, Innis M, Liggett SB . Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties Biochemistry 1994 33: 9414–9419.

    Article  CAS  PubMed  Google Scholar 

  7. Green SA, Cole G, Jacinto M, Innis M, Liggett SB . A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor J Biol Chem 1993 268: 23116–23121.

    CAS  PubMed  Google Scholar 

  8. McGraw DW, Forbes SL, Kramer LA, Liggett SB . Polymorphisms of the 5′ leader cistron of the human beta2-adrenergic receptor regulate receptor expression J Clin Invest 1998 102: 1927–1932.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Green SA, Turki J, Hall IP, Liggett SB . Implications of genetic variability of human beta 2-adrenergic receptor structure Pulm Pharmac 1995 8: 1–10.

    Article  CAS  Google Scholar 

  10. Lin RCY, Ericsson JO, Benjafield AV, Morris BJ . Association of beta2-adrenoceptor Gln27Glu variant with body weight but not hypertension Am J Hypertens 2001 14: 1201–1204.

    Article  CAS  PubMed  Google Scholar 

  11. Large V, Hellstrom L, Reynisdottir S et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function J Clin Invest 1997 100: 3005–3013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hellstrom L, Large V, Reynisdottir S, Wahrenberg H, Arner P . The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females J Intern Med 1999 245: 253–259.

    Article  CAS  PubMed  Google Scholar 

  13. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K . Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus Diabetologia 1999 42: 98–101.

    Article  CAS  PubMed  Google Scholar 

  14. Yamada K, Ishiyama-Shigemoto S, Ichikawa F et al. Polymorphism in the 5′-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes J Clin Endocrinol Metab 1999 84: 1754–1757.

    CAS  PubMed  Google Scholar 

  15. Mori Y, Kim-Motoyama H, Ito Y et al. The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men Biochem Biophys Res Commun 1999 258: 138–140.

    Article  CAS  PubMed  Google Scholar 

  16. Meirhaeghe A, Helbecque N, Cottel D, Amouyel P . Beta2-adrenoceptor gene polymorphism, body weight, and physical activity Lancet 1999 353: 896.

    CAS  PubMed  Google Scholar 

  17. Meirhaeghe A, Helbecque N, Cottel D, Amouyel P . Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population Int J Obes Relat Metab Disord 2000 24: 382–387.

    CAS  PubMed  Google Scholar 

  18. Macho Azcarate T, Marti del Moral A, Martinez Hernandez JA . [Genetic studies of obesity in humans.] Med Clin (Barc) 2000 115: 103–110.

    Article  CAS  Google Scholar 

  19. Ehrenborg E, Skogsberg Ruotolo G, Large V, Eriksson P, Arner P, Hamsten A . The Q/E27 polymorphism in the β2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins J Intern Med 2000 247: 651.

    Article  CAS  PubMed  Google Scholar 

  20. Echwald SM, Sorensen TI, Tybjaerg-Hansen A, Andersen T, Pedersen O . Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men Diabetes 1998 47: 1657–1658.

    Article  CAS  PubMed  Google Scholar 

  21. Kortner B, Wolf A, Wendt D, Beisiegel U, Evans D . Lack of association between a human beta-2 adrenoceptor gene polymorphism (gln27glu) and morbid obesity Int J Obes Relat Metab Disord 1999 23: 1099–1100.

    Article  CAS  PubMed  Google Scholar 

  22. Oberkofler H, Esterbauer H, Hell E, Krempler F, Patsch W . The Gln27Glu polymorphism in the beta2-adrenergic receptor gene is not associated with morbid obesity in Austrian women Int J Obes Relat Metab Disord 2000 24: 388–390.

    Article  CAS  PubMed  Google Scholar 

  23. Meirhaeghe A, Luan J, Selberg-Franks P et al. The effect of the Gly16Arg polymorphism of the beta(2)-adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity J Clin Endocrinol Metab 2001 86: 5881–5887.

    CAS  PubMed  Google Scholar 

  24. Moore GE, Shuldiner AR, Zmuda JM, Ferrell RE, McCole SD, Hagberg JM . Obesity gene variant and elite endurance performance Metabolism 2001 50: 1391.

    Article  CAS  PubMed  Google Scholar 

  25. Corbalán MS, Marti A, Martínez-González MA, Martínez JA . The 27Glu polymorphism of the β2-adrenergic receptor gene interacts with physical activity on obesity risk among female subjects Clin Genet (in press)

  26. Morris JN, Hardman AE . Walking to health Sports Med 1997 23: 306–332.

    Article  CAS  PubMed  Google Scholar 

  27. Buemann B, Schierning B, Toubro S et al. The association between the val/ala-55 polymorphism of the uncoupling protein 2 gene and exercise efficiency Int J Obes Relat Metab Disord 2001 25: 467–471.

    Article  CAS  PubMed  Google Scholar 

  28. Ranallo RF, Rhodes EC . Lipid metabolism during exercise Sports Med 1998 26: 29–42.

    Article  CAS  PubMed  Google Scholar 

  29. Galbo H . Exercise Physiology: Humoral function Sports Sci Rev 1992 1: 65.

    Google Scholar 

  30. Wasserman's principles of exercise testing and interpretation 2nd edn Lea & Febiger: Philadelpphia, PA 1994.

  31. WHO. Technical Report Series no. 894 2000 i–xii: 1–253.

  32. Astrup A . Healthy lifestyles in Europe: prevention of obesity and type II diabetes by diet and physical activity Public Health Nutr 2001 4: 499–515.

    Article  CAS  PubMed  Google Scholar 

  33. Tai MM, Castillo TP, Pi-Sunyer FX . Thermic effect of food during each phase of the menstrual cycle Am J Clin Nutr 1997 66: 1110–1115.

    Article  CAS  PubMed  Google Scholar 

  34. Balado D (ed). McArdle, Katch and Katch's exercise physiology 4th edn Williams & Wilkins: Baltimore, Maryland 1996.

    Google Scholar 

  35. Ferrannini E . The theoretical bases of indirect calorimetry: a review Metabolism 1988 37: 287–301.

    Article  CAS  PubMed  Google Scholar 

  36. Marques-Lopes I, Ansorena D, Astiasaran I, Forga L, Martinez JA . Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men Am J Clin Nutr 2001 73: 253–261.

    Article  CAS  PubMed  Google Scholar 

  37. Magalini FI, Marcelletti C, Fegiz G, Del Grande G, Mencuccini A . MEDISYSTEM (R)—a modular computer architecture for integrated management of clinical information and images. Evaluation after one year of use in hospital departments J Clin Comput 1989 17: 89–98.

    CAS  PubMed  Google Scholar 

  38. Boomsma F, Alberts G, van der Hoorn FA, Man in't Veld AJ, Schalekamp MA . Simultaneous determination of free catecholamines and epinine and estimation of total epinine and dopamine in plasma and urine by high-performance liquid chromatography with fluorimetric detection J Chromatogr 1992 574: 109–117.

    Article  CAS  PubMed  Google Scholar 

  39. Ukkola O, Tremblay A, Bouchard C . Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding Int J Obes Relat Metab Disord 2001 25: 1604–1608.

    Article  CAS  PubMed  Google Scholar 

  40. Ahlborg G, Felig P, Hagenfeldt L, Hendler R, Wahren J . Substrate turnover during prolonged exercise in man. Splachnic and leg metabolism of glucose, free fatty acids, and amino acids J Clin Invest 1974 53: 1080.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. McGarry JD, Foster DW . Regulation of hepatic fatty acid oxidation and ketone body production A Rev Biochem J 1980 49: 395.

    Article  CAS  Google Scholar 

  42. Iwamoto N, Ogawa Y, Kajihara S et al. Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver Clin Chim Acta 2001 314: 85–91.

    Article  CAS  PubMed  Google Scholar 

  43. Rosmond R, Ukkola O, Chagnon M, Bouchard C, Bjorntorp P . Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men J Intern Med 2000 248: 239–244.

    Article  CAS  PubMed  Google Scholar 

  44. Reaven GM, Lithell H, Landsberg L . Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system New Engl J Med 1996 334: 374–381.

    Article  CAS  PubMed  Google Scholar 

  45. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F . High triglycerides and low HDL cholesterol and blood pressure and risk of ischemic heart disease Hypertension 2000 36: 226–232.

    Article  CAS  PubMed  Google Scholar 

  46. Ho SC, Chen YM, Woo JL, Leung SS, Lam TH, Janus ED . Association between simple anthropometric indices and cardiovascular risk factors Int J Obes Relat Metab Disord 2001 25: 1689–1697.

    Article  CAS  PubMed  Google Scholar 

  47. Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, Manning B, Strosberg AD, Stern MP, Raben N . Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene New Engl J Med 1995 333: 343.

    Article  CAS  PubMed  Google Scholar 

  48. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC . Association of a polymorphism in the beta 3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns New Engl J Med 1995 333: 348.

    Article  CAS  PubMed  Google Scholar 

  49. Corbalan MS, Marti A, Martinez-Gonzalez MA, Forga L, Martinez JA . The influence of a β3-adrenergic polymorphism on the risk of obesity is evident in young adults Int J Obes Relat Metab Disord 2001 25 (Suppl 2): S45.

    Google Scholar 

  50. Arner P . Regulation of lipolysis in fat cells Diabetes Rev 1996 4: 450–463.

    Google Scholar 

  51. Jensen MD . Lipolysis: contribution of regional fat A Rev Nutr 1997 17: 127–139.

    Article  CAS  Google Scholar 

  52. Arner P . Catecholamine-induced lipolysis in obesity Int J Obes Relat Metab Disord 1999 23 (Suppl 1): 10–13.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are indebted to Thomas Rau and JL Vizmanos for their valuable counselling in Genetics. Special thanks go to MJ Calasanz and JP Román for their statistical advice. We thank Ana Lorente and Verónica Ciaurriz for the biochemical assays. Gratitude is expressed to Dr J Calabuig and the staff of the University Clinic for their valuable help during the maximal and submaximal trials. Financial support from Línea Especial and Gobierno de Navarra is gratefully recognized. T Macho was supported in part by the Deutsche Akademische Austauschdienst.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to JA Martinez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Macho-Azcarate, T., Marti, A., González, A. et al. Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women. Int J Obes 26, 1434–1441 (2002). https://doi.org/10.1038/sj.ijo.0802129

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802129

Keywords

This article is cited by

Search

Quick links